Clinical trial

Tiotropium / Respimat One Year Study in COPD.

NCT00387088

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE3

Study timeline

Study start (unknown)2006-09-01Date precision: month

Registry last updated2014-05-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

RespimatDEVICE

TiotropiumDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

TaipeiTaiwan6 AthensGreece5 SeoulSouth Korea3 CincinnatiOhio, United States3 BerlinGermany3 BeijingChina3 ShanghaiChina3 SingaporeSingapore3 Cape TownSouth Africa3 NîmesFrance3 Los AngelesCalifornia, United States2 DallasTexas, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00387088 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.